ArticleBMJ neurology open2022

Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study.

Marios C Pantzaris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.